Page 5,022«..1020..5,0215,0225,0235,024..5,0305,040..»

Delay in seeking stroke care costs women best treatment

Posted: Published on July 26th, 2013

Public release date: 25-Jul-2013 [ | E-mail | Share ] Contact: Maggie Francis maggie.francis@heart.org 214-706-1382 American Heart Association Women with clot-caused strokes are less likely than men to arrive at the hospital in time to receive the best treatment, according to a European study reported in the American Heart Association journal Stroke. In the study, 11 percent of women with acute ischemic strokes were treated with the clot-dissolving medication alteplase, compared with 14 percent of men. Study participants included 5,515 patients at 12 hospitals in the Netherlands. Researchers found no gender gap when they looked only at patients who arrived at the hospital within four hours of the onset of symptoms in this study. Forty-two percent of men and women arriving within the four-hour window received alteplase. "Our study showed that women in the Netherlands were treated just as often with thrombolytic agents as men once they arrived in time for treatment," said Inger de Ridder, M.D., lead author of the study and AIOS Resident of Neurology at Erasmus University Medical Center in Rotterdam, The Netherlands. The gender gap in treatment may be due to delays in getting to the hospital, researchers said. Women arrived at the hospital an average … Continue reading →

Comments Off on Delay in seeking stroke care costs women best treatment

Neurodegenerative Diseases Market to 2018 – New Product Entries in Both Niche and Broader Parkinson's Disease …

Posted: Published on July 26th, 2013

DUBLIN, Ireland, July 25, 2013 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/7xz9dc/neurodegenerative) has announced the addition of the "Neurodegenerative Diseases Market to 2018 - New product entries in both niche and broader Parkinson's disease treatment will boost market despite patent cliff" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Neurodegenerative Diseases Market to 2018 - New product entries in both niche and broader Parkinson's disease treatment will boost market despite patent cliff. A highly dynamic market scenario is expected in Neurodegenerative diseases in the next few years, with a number of patent expiries and anticipated new drug approvals. The market for Alzheimer's disease has not seen any recent major breakthroughs, and is expected to experience a decline due to the patent expiry of several major products. The market for Parkinson's disease, on the other hand, is expected to experience growth due to the anticipated approval of expensive products such as Duodopa in the US, in spite of the fact that it will soon hit its own patent cliff. Additionally, the overall aging of populations the developed world is expected to increase the number of patients suffering from these diseases due to their relatively high prevalence in the elderly. Scope - The report … Continue reading →

Posted in Parkinson's Treatment | Comments Off on Neurodegenerative Diseases Market to 2018 – New Product Entries in Both Niche and Broader Parkinson's Disease …

Statin Use May Reduce Parkinson's Risk, Study Says

Posted: Published on July 26th, 2013

By Maureen Salamon HealthDay Reporter WEDNESDAY, July 24 (HealthDay News) -- Millions of Americans take statins to lower their stroke and heart attack risks, but new research from Taiwan suggests the drug may offer another health benefit: cutting the odds of developing Parkinson's disease. Analyzing nearly 44,000 patients, scientists found that those who discontinued taking fat-soluble statins such as simvastatin (Zocor) or atorvastatin (Lipitor) were about 58 percent more likely to develop Parkinson's than those who kept taking the drugs. Fat-soluble statins are believed to cross the blood-brain barrier, unlike water-soluble statins such as rosuvastatin (Crestor) and pravastatin (Pravachol). The drugs may decrease inflammation and even modify dopamine pathways in the brain, which are linked to Parkinson's, the study authors suggested. "We are more glad than surprised to demonstrate the relationship," said study author Dr. Jou-Wei Lin, a cardiologist at National Taiwan University Hospital. "Our analysis is observational . . . and further clinical trials targeting the association between statin use and Parkinson's disease are still needed." The study is published online July 24 in the journal Neurology. One in four Americans aged 45 and older takes a statin, according to Harvard Health. The drugs are used to lower cholesterol … Continue reading →

Posted in Parkinson's Treatment | Comments Off on Statin Use May Reduce Parkinson's Risk, Study Says

NIH Begins Gene Therapy Trial for Parkinson s Disease

Posted: Published on July 26th, 2013

Home Mail News Sports Finance Weather Games Groups Answers Flickr More omg! Shine Movies Music TV Health Shopping Travel Autos Homes Search News Search Web Sign In Mail Help Account Info Help Suggestions Yahoo! Home Video Photos GMA Year in Review LiveRoom Odd Comics Travel Opinion Trending Now Who Knew? Weather The Upbeat U.S. U.S. Video GMA Education Religion Crimes and Trials The Lookout Local Contributor Network Year In Review World World Video Middle East Europe Latin America Africa Asia Canada Australia/Antarctica Business Video Exclusives Today's Markets Stocks Personal Finance Marketplace Entertainment Video Clinton Concert Celebrity TV Movies Music Fashion Books Arts Theater Dear Abby Comics Odd News Sports Video NFL MLB NBA NCAAF NCAAB Soccer Cycling NHL Tennis Golf Boxing Motor Sports MMA Olympics Tech Gadgets Wireless Apple Social Media Security Open Source Gaming Apps This Could Be Big Upgrade Your Life Politics Remake America The Issues Women and Politics Press Releases Video Science Science Video Weather News Space / Astronomy Pets Dinosaurs / Fossils Biotech Energy Green Health Video Weight Loss Cancer Sexual Health Medications/Drugs Parenting/Kids Seniors/Aging Diseases/Conditions Blogs The Lookout The Sideshow Around the World Katie's Take Power Players This Could Be Big Newsmakers Trending Now Just … Continue reading →

Posted in Parkinson's Treatment | Comments Off on NIH Begins Gene Therapy Trial for Parkinson s Disease

Acorda Therapeutics to Host Conference Call to Discuss Second Quarter 2013 Financial Results on August 1, 2013

Posted: Published on July 26th, 2013

ARDSLEY, N.Y.--(BUSINESS WIRE)-- Acorda Therapeutics, Inc. (ACOR) today announced that it will host a conference call and live webcast to report its second quarter 2013 financial results on Thursday, August 1 at 8:30 a.m. ET. To participate in the conference call, please dial 866-953-6860 (domestic) or 617-399-3484 (international) and reference the access code 76844097. The presentation will be available via a live webcast on the Investors section of http://www.acorda.com. Please log in approximately 5 minutes before the scheduled time of the presentation to ensure a timely connection. A replay of the call will be available from 10:30 a.m. ET on August 1, 2013 until midnight on August 29, 2013. To access the replay, please dial 888-286-8010 (domestic) or 617-801-6888 (international) and reference the access code 84613445. An archived version of the webcast will be available for 30 days in the Investor Relations section of the Acorda website at http://www.acorda.com. About Acorda Therapeutics Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with MS, spinal cord injury and other neurological conditions. Acorda markets AMPYRA (dalfampridine) Extended Release Tablets, 10 mg, in the United States as a treatment to improve walking in … Continue reading →

Posted in Cerebral Palsy Treatment | Comments Off on Acorda Therapeutics to Host Conference Call to Discuss Second Quarter 2013 Financial Results on August 1, 2013

Charlottesville, Va. brain injury center for veterans shuttered

Posted: Published on July 26th, 2013

CHARLOTTESVILLE, Va. Rising costs and low patient volume have prompted the federal government to close the Charlottesville location of a facility that treated military members and veterans with traumatic brain injuries. The Defense and Veterans Brain Injury Center released its last patient at its city location in May, and most of its staff left last month, a spokeswoman confirmed. The center, which was located on East High Street, had been in the area since 1999. The Brain Injury Center is part of the U.S. militarys health system and is component of the Defense Centers of Excellence for Psychological Health and Traumatic Brain Injury. Because the facilities were unique and intensive, they handled a small number of patients and incurred high costs compared to other facilities, the centers website states. The government also closed a similar facility in Johnston, Pa., last month. University of Virginia Health System Dr. Jeffrey Barth, who served as the centers primary neuropsychology consultant, said he was disappointed to see the center close. Our job at [the Brain Injury Center] was to help to normalize these folks to introduce them [back] to daily activities, said Barth. The center employed 26 contracted staff members who filled about 18 … Continue reading →

Posted in Brain Injury Treatment | Comments Off on Charlottesville, Va. brain injury center for veterans shuttered

Feds close veterans brain injury center in Charlottesville

Posted: Published on July 26th, 2013

Charlottesville brain injury center closes CHARLOTTESVILLE, Va. The federal government has closed a center in Charlottesville that provided treatment for military members and veterans with traumatic brain injuries. The Defense and Veterans Brain Injury Center says on its website that the Charlottesville facility had a low patient volume and high costs compared to other facilities. A similar facility in Johnson, Pa., also has been closed. Kathleen Taylor, a spokeswoman for the national organization, told The Daily Progress that the Charlottesville center needed more than $4 million in technology upgrades to ensure compliance with Department of Defense standards. "This program focused on community reintegration activities and targeted skills necessary for return to duty/military service and community reintegration," Taylor told the newspaper in an email. "It offered interactive therapy programs designed to address the individual needs and goals of each patient." She said these services are provided elsewhere in the military health system. U.S. Sen. Tim Kaine, D-Va., said the center's closing is an example of why Congress needs to find a budget resolution that preserves such facilities and programs. "I know a Virginian who received superb treatment for their brain injury at this facility," he said in a statement. "I have … Continue reading →

Posted in Brain Injury Treatment | Comments Off on Feds close veterans brain injury center in Charlottesville

Government shuts down Charlottesville brain-injury facility

Posted: Published on July 26th, 2013

Rising costs and low patient volume have prompted the federal government to close the Charlottesville location of a facility that treated military members and veterans with traumatic brain injuries. The Defense and Veterans Brain Injury Center released its last patient at its city location in May, and most of its staff left last month, a spokeswoman confirmed. The center, which was on East High Street, had been in the area since 1999. The Brain Injury Center is part of the U.S. militarys health system and is a component of the Defense Centers of Excellence for Psychological Health and Traumatic Brain Injury. Because the facilities were unique and intensive, they handled a small number of patients and incurred high costs compared to other facilities, the centers website states. The government also closed a similar facility in Johnston, Pa., last month. University of Virginia Health Systems Dr. Jeffrey Barth, who served as the centers primary neuropsychology consultant, said he was disappointed to see the center close. Our job at (the Brain Injury Center) was to help to normalize these folks ... to introduce them (back) to daily activities, Barth said. The center employed 26 contracted staff members who filled about 18 full-time … Continue reading →

Posted in Brain Injury Treatment | Comments Off on Government shuts down Charlottesville brain-injury facility

Gillard on Abbott: 'Oh God, give me strength'

Posted: Published on July 26th, 2013

Former prime minister Julia Gillard says gender issues are more easily glossed over than racism. Photo: Alex Ellinghausen Former prime minister Julia Gillard says Australians would have been more outraged at her treatment as a woman if she were black. In a lengthy interview conducted while Ms Gillard was still Labor leader and published in the latest The Monthly, Ms Gillard said politics had become more combative, particularly in recent years under minority government in Australia. ''Is the stuff against Barack Obama because he's African American? ... Or would they have played as hard as that against any successful Democrat? Well, I suspect it's a bit of both,'' she said. ''I think some of the stuff about me, because it is about gender, gets glossed over more easily.'' Advertisement In March 2011, Opposition Leader Tony Abbott stood at a rally against the carbon tax beside signs that read, ''Juliar: Bob Browns [sic] Bitch'' and ''Ditch the Witch''. ''If I was the first indigenous prime minister, and (Tony) Abbott had gone out and stood next to a sign that said, 'Ditch the black bastard', I reckon that would be the end of a political career,'' Ms Gillard said. ''And it's not … Continue reading →

Posted in MS Treatment | Comments Off on Gillard on Abbott: 'Oh God, give me strength'

Conman facing life sentence for murdering secret lover

Posted: Published on July 26th, 2013

Ms Lee - the owner of a ''luxury cattery'' - suffered fatal head wounds from ''a sustained attack with a blunt object'' and was mutilated by Ryan in a bid to get rid of DNA evidence, the jury heard. Assistant Chief Constable Ruth Purdie, of Cheshire Police, said: ''David Ryan gave Diana attention and affection and preyed on her trusting and kind nature for his own ends. We now know that his intentions toward Diana were fuelled by greed and Ryan's intention to exploit her financially to try and recover himself from the mountain of debt he faced. ''We have been left in little doubt that Ryan's attack on Diana - a diminutive and gentle lady - was brutal and sadistic. "He showed contempt and compounded his disregard for her when he did his utmost to remove DNA evidence and then destroy her body.'' She added: ''Although Ryan refused to admit his guilt in this horrific murder, the prosecution were able to prove that he concocted a web of lies and brutally murdered a woman who had done nothing more than fall for the charm of a conman.'' Ryan, with greying, shoulder-length hair and wearing a grey suit, white shirt … Continue reading →

Posted in MS Treatment | Comments Off on Conman facing life sentence for murdering secret lover

Page 5,022«..1020..5,0215,0225,0235,024..5,0305,040..»